OCP Pretreatment in PCOS Patients Undergoing ICSI Using Antagonist Protocol

Inclusion criteria

• . Age 18-39 years of age.
• . BMI 18-29 Kg/m2
• . Polycystic ovary syndrome, diagnosed - according to the revised 2003 consensus on diagnostic criteria of polycystic ovary syndrome by the Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group - by the presence of two of the following three diagnostic features:
• . Oligo- or anovulation \[defined as fewer than eight episodes of menstrual bleeding per year or menses that occur at intervals greater than 35 days\].
• . Clinical hyperandrogenism \[defined by the presence of hirsutism (assessed by a modified Ferriman-Gallwey score ≥ 8), acne or androgenic alopecia\] and/or biochemical signs of hyperandrogenism \[defined by elevated free androgen index\]
• . Polycystic ovaries \[defined as presence of 12 or more follicles in each ovary measuring 2 - 9 mm in diameter, and/or increased ovarian volume \> 10 mL) in the early follicular phase (cycle days 3 - 5) in regularly menstruating women. Oligo-/amenorrhoeic women should be scanned either at random or between days 3 and 5 after a progestin-induced withdrawal bleeding. This definition does not apply to women taking oral contraceptive pills, since their use modifies ovarian morphology in normal women and putatively in women with PCO.